Insider Transactions in Q2 2024 at Imara Inc. (IMRA)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,250
-63.91%
|
$93,500
$22.6 P/Share
|
|
Jun 27
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+50.0%
|
$8,500
$2.48 P/Share
|
|
Jun 25
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Indirect |
12,000
-0.55%
|
$252,000
$21.96 P/Share
|
|
Jun 17
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
1,270
-0.93%
|
$26,670
$21.48 P/Share
|
|
Jun 06
2024
|
Anish Patel CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
1,133
-100.0%
|
$22,660
$20.06 P/Share
|
|
Jun 06
2024
|
Anish Patel CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,133
+50.0%
|
$2,266
$2.48 P/Share
|
|
May 29
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-91.15%
|
$264,000
$22.04 P/Share
|
|
May 29
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$12,000
$1.12 P/Share
|
|
May 28
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
12,000
-84.6%
|
$276,000
$23.59 P/Share
|
|
May 28
2024
|
Samuel Kintz PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$12,000
$1.12 P/Share
|
|
May 28
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,250
-81.47%
|
$97,750
$23.55 P/Share
|
|
May 28
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,250
+50.0%
|
$8,500
$2.48 P/Share
|
|
May 16
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
1,270
-0.93%
|
$29,210
$23.74 P/Share
|
|
May 16
2024
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
1,033,300
-11.55%
|
$22,732,600
$22.14 P/Share
|
|
May 16
2024
|
Rishi Gupta Director |
SELL
Open market or private sale
|
Indirect |
1,033,300
-11.55%
|
$22,732,600
$22.14 P/Share
|
|
May 14
2024
|
Anish Patel CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
1,107
-100.0%
|
$27,675
$25.0 P/Share
|
|
May 14
2024
|
Anish Patel CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,107
+50.0%
|
$2,214
$2.48 P/Share
|
|
May 09
2024
|
Anish Patel CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
260
-100.0%
|
$6,500
$25.06 P/Share
|
|
May 09
2024
|
Anish Patel CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
260
+50.0%
|
$520
$2.48 P/Share
|
|
May 06
2024
|
Anish Patel CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,875
-100.0%
|
$107,250
$22.72 P/Share
|
|
May 06
2024
|
Anish Patel CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,875
+50.0%
|
$9,750
$2.48 P/Share
|
|
May 03
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$22,000
$22.5 P/Share
|
|
May 03
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$2,000
$2.48 P/Share
|
|
Apr 29
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,250
-100.0%
|
$52,000
$16.97 P/Share
|
|
Apr 29
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
3,250
+50.0%
|
$6,500
$2.48 P/Share
|
|
Apr 29
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-95.78%
|
$216,000
$18.17 P/Share
|
|
Apr 29
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$12,000
$1.12 P/Share
|
|
Apr 25
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
12,000
-100.0%
|
$192,000
$16.89 P/Share
|
|
Apr 25
2024
|
Samuel Kintz PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+50.0%
|
$12,000
$1.12 P/Share
|
|
Apr 15
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
1,270
-0.46%
|
$25,400
$20.31 P/Share
|
|
Apr 11
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,000
-63.49%
|
$336,000
$24.46 P/Share
|
|
Apr 11
2024
|
Benjamin Hohl CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+50.0%
|
$28,000
$2.48 P/Share
|
|
Apr 11
2024
|
Samuel Kintz PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
47,709
-100.0%
|
$1,192,725
$25.04 P/Share
|
|
Apr 11
2024
|
Samuel Kintz PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,709
+50.0%
|
$47,709
$1.12 P/Share
|
|
Apr 11
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
30,000
-100.0%
|
$750,000
$25.04 P/Share
|
|
Apr 11
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+50.0%
|
$30,000
$1.12 P/Share
|
|
Apr 11
2024
|
Anish Patel CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
17,500
-100.0%
|
$437,500
$25.03 P/Share
|
|
Apr 11
2024
|
Anish Patel CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,903
+45.99%
|
$29,806
$2.48 P/Share
|
|
Apr 11
2024
|
Helen Louise Collins CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-100.0%
|
$500,000
$25.07 P/Share
|
|
Apr 11
2024
|
Helen Louise Collins CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$40,000
$2.48 P/Share
|
|
Apr 11
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Indirect |
649
-2.22%
|
$16,225
$25.0 P/Share
|
|
Apr 11
2024
|
Richard A. Heyman |
SELL
Open market or private sale
|
Direct |
5,045
-97.34%
|
$126,125
$25.03 P/Share
|
|
Apr 11
2024
|
Rahul D. Ballal |
SELL
Open market or private sale
|
Direct |
53,400
-32.05%
|
$1,281,600
$24.45 P/Share
|
|
Apr 11
2024
|
Rahul D. Ballal |
BUY
Exercise of conversion of derivative security
|
Direct |
53,400
+23.2%
|
$854,400
$16.14 P/Share
|
|
Apr 10
2024
|
Rahul D. Ballal |
SELL
Open market or private sale
|
Direct |
13,600
-37.84%
|
$285,600
$21.01 P/Share
|
|
Apr 10
2024
|
Rahul D. Ballal |
BUY
Exercise of conversion of derivative security
|
Direct |
13,600
+27.45%
|
$163,200
$12.6 P/Share
|
|
Apr 08
2024
|
Anish Patel CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
4,875
-37.64%
|
$87,750
$18.95 P/Share
|
|
Apr 04
2024
|
Rahul D. Ballal |
SELL
Open market or private sale
|
Direct |
3,485
-13.49%
|
$66,215
$19.15 P/Share
|
|
Apr 04
2024
|
Rahul D. Ballal |
BUY
Exercise of conversion of derivative security
|
Direct |
3,485
+11.89%
|
$41,820
$12.6 P/Share
|
|
Apr 01
2024
|
Joseph P Lyssikatos CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
12,000
-72.95%
|
$216,000
$18.63 P/Share
|